File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Pharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT)

TitlePharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT)
Authors
KeywordsDacomitinib
Gastrostomy tube feeding
Head and neck
PF-00299804
Squamous-cell cancer
Issue Date2015
PublisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6997
Citation
Investigational New Drugs, 2015, v. 33 n. 4, p. 895-900 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/214355
ISSN
2023 Impact Factor: 3.0
2023 SCImago Journal Rankings: 1.086
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChiu, JWY-
dc.contributor.authorChan, K-
dc.contributor.authorChen, EX-
dc.contributor.authorSiu, LL-
dc.contributor.authorAbdul Razak, AR-
dc.date.accessioned2015-08-21T11:18:10Z-
dc.date.available2015-08-21T11:18:10Z-
dc.date.issued2015-
dc.identifier.citationInvestigational New Drugs, 2015, v. 33 n. 4, p. 895-900-
dc.identifier.issn0167-6997-
dc.identifier.urihttp://hdl.handle.net/10722/214355-
dc.languageeng-
dc.publisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0167-6997-
dc.relation.ispartofInvestigational New Drugs-
dc.rightsThe final publication is available at Springer via http://dx.doi.org/10.1007/s10637-015-0245-3-
dc.subjectDacomitinib-
dc.subjectGastrostomy tube feeding-
dc.subjectHead and neck-
dc.subjectPF-00299804-
dc.subjectSquamous-cell cancer-
dc.titlePharmacokinetic assessment of dacomitinib (pan-HER tyrosine kinase inhibitor) in patients with locally advanced head and neck squamous cell carcinoma (LA SCCHN) following administration through a gastrostomy feeding tube (GT)-
dc.typeArticle-
dc.identifier.emailChiu, JWY: jwychiu@hku.hk-
dc.identifier.authorityChiu, JWY=rp01917-
dc.identifier.doi10.1007/s10637-015-0245-3-
dc.identifier.pmid25937431-
dc.identifier.scopuseid_2-s2.0-84943363050-
dc.identifier.hkuros248097-
dc.identifier.volume33-
dc.identifier.issue4-
dc.identifier.spage895-
dc.identifier.epage900-
dc.identifier.isiWOS:000357462700012-
dc.publisher.placeUnited States-
dc.identifier.issnl0167-6997-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats